Thyroid disorders in pregnancy

Current Opinion in Obstetrics and Gynecology

Volumn 17, Issue 2, 2005, Pages 123-127

  Lao, Terence T ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Hyperthyroidism; Hypothyroidism; Neurological development of offspring; Pregnancy complications; Thyroid antibodies

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CARBIMAZOLE; IRON; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROXINE;

ANTIBODY TITER; BRAIN DEVELOPMENT; BREAST FEEDING; CHILD DEVELOPMENT; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG SAFETY; FETUS DEVELOPMENT; FETUS DISEASE; FETUS ECHOGRAPHY; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GENE MUTATION; GRAVES DISEASE; HASHIMOTO DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; IODINE DEFICIENCY; NEWBORN DISEASE; PREGNANCY COMPLICATION; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SKIN APLASIA; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; THYROID CARCINOMA; THYROID DISEASE; THYROID SURGERY; THYROTOXICOSIS; THYROXINE BLOOD LEVEL; TREATMENT INDICATION;

EID: 15944417486     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000162179.15360.08     Document Type: Review

References (34)

1. Glinoer D. Management of hypo- and hyperthyroidism during pregnancy. Growth Hormone & Igf Research 2003; 13(suppl A):S45-S54. This is a thorough and comprehensive review of the important causes and management of hyper- and hypothyroidism in pregnancy, and covered most of the important and latest reported studies on the subject.
2. Kung AWC, Chau MT, Lao TT, et al. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab 2002; 87:1010-1014.
3. Glinoer D, Soto MF, Bourdoux P, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 1991; 73:421-427.
4. Kato K, Mostafa MH, Mann K, et al. The human chorionic gonadotropin molecule from patients with trophoblastic diseases has a high thyrotropic activity but is less active in the ovary. Gynecol Endocrinol 2004; 18:269-277. This paper reported the investigation into the molecular variant of human chorionic gonadotropin that has a greater effect on the thyroid than on the ovary.
5. Goodwin TM, Montoro M, Mestman JH, et al. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 1992; 75:1333-1337.
6. Kimura M, Amino N, Tamaki H, et al. Gestational thyrotoxicosis and hyperemesis gravidarum: possible role of hCG with higher stimulating activity. Clin Endocrinol 1993; 38:345-350.
7. Lao TTH, Chin RKH, Swaminathan R, Lam YM. Maternal thyroid hormones and outcome of pre-eclamptic pregnancies. Br J Obstet Gynaecol 1990; 97:71-74.
8. Larijani B, Marsoosi V, Aghakhani S, et al. Thyroid hormone alteration in pre-eclamptic women. Gynecol Endocrinol 2004; 18:97-100. The relationship between mild and severe pre-eclampsia with changes in maternal thyroid function is elucidated in this paper.
9. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341:549-555.
10. Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in early infancy. Clin Endocrinol 1999; 50:149-155.
11. Andersen S, Bruun NH, Pedersen KM, Laurberg P. Biologic variation is important for interpretation of thyroid function tests. Thyroid 2003; 13:1069-1078. This paper clarifies the effect of pregnancy on the interpretation of thyroid-function test results.
12. Pop VJ, Brouwers EP, Vader HL, et al. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol 2003; 59:282-288. An important report that provides clear evidence of the adverse effect of maternal hypothyroxinaemia on neuro-psychointellectual development in early childhood.
13. Shah MS, Davies TF, Stagnaro-Green A. The thyroid during pregnancy: a physiological and pathological stress test. Minerva Endocrinologica 2003; 28:233-245. An interesting paper that explains the interaction between pregnancy and the thyroid.
14. Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004; 351:241-249. This is an important report that provides proof of the need to increase thyroxine replacement for women with hypothyroidism during pregnancy.
15. Pop VJ, Brouwers EP, Wijnen H, et al. Low concentrations of maternal thyroxin during early gestation: a risk factor of breech presentation? Br J Obstet Gynaecol 2004; 111:925-930. A hitherto unknown phenomenon and explanation for breech presentation at term is given in this paper, although the underlying mechanism remains to be determined.
16. Lejeune B, Grun JP, De Nayer Ph, et al. Antithyroid antibodies underlying thyroid abnormalities and miscarriage or pregnancy induced hypertension. Br J Obstet Gynaecol 1993; 100:669-672.
17. Anselmo J, Cao D, Karrison T, et al. Fetal loss associated with excess thyroid hormone exposure. JAMA 2004; 292:691-695. A convincing piece of evidence for the toxic effect of excess thyroxine on the fetus, using a rare genetic condition, is presented by the authors.
18. Stagnaro-Green A, Roman SH, Cobin RH, et al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990; 264:1422-1425.
19. Prummel MF, Wiersinga WM. Thyroid autoimmunity and miscarriage. Eur J Endocrinol 2004; 150:751-755. This paper confirmed the relationship between thyroid antibodies and spontaneous miscarriage.
20. Kriplani A, Buckshee K, Bhargava VL, et al. Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy. Eur J Obstet Gynecol Reprod Biol 1994; 54:159-163.
21. Read CH Jr, Tansey MJ, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab 2004; 89:4229-4233. This important report demonstrated the long-term safety of radioactive iodine on the health and reproductive performance of women treated before the age of 20.
22. Chow SM, Yau S, Lee SH, et al. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment. Int J Radiat Oncol Biol Phys 2004; 59:992-1000. The fetal effects of maternal radioactive iodine treatment in the human cannot be determined in prospective studies for obvious reasons, and the unique experience reported in this paper provides much-needed information on this issue.
23. Cohen O, Pinhas-Hamiel O, Sivan E, et al. Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy. Pren Diagn 2003; 23:740-742. The feasibility and important experience of reliably examining the fetal thyroid by ultrasound during pregnancy as reported here would be most helpful for obstetricians in their practice.
24. Nachum Z, Rakover Y, Weiner E, Shalev E. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol 2003; 189:159-165. This paper provides evidence to support the feasibility and safety of fetal blood sampling in the assessment of thyroid function.
25. Momotani N, Yamashita R, Yoshimoto M, et al. Recovery from foetal hypothyroidism: evidence for the safety of breast feeding while taking propylthiouracil. Clin Endocrinol 1989; 31:591-596.
26. Azizi F, Bahrainian M, Khamseh ME, Khoshniat M. Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Pediatr Endocrinol 2003; 16:1239-1243. This is the only report on the long-term safety of methimazole on the offspring of mothers taking this drug while nursing.
27. Roberts CG, Ladenson PW. Hypothyroidism. Lancet 2004; 363:793-803. This paper provides an in-depth review of hypothyroidism and its management, the understanding of which is important for the optimal management of hypothyroid patients before and during pregnancy.
28. Lazarus JH. Thyroid dysfunction: reproduction and postpartum thyroiditis. Sem Reprod Med 2002; 20:381-388.
29. Leung AS, Millar LK, Koonings PP, et al. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993; 81:349-353.
30. Wasserstrum N, Anania CA. Perinatal consequences of maternal hypothyroidism in early pregnancy and inadequate replacement. Clin Endocrinol 1995; 42:353-358.
31. Blazer S, Moreh-Waterman Y, Miller-Lotan R, et al. Maternal hypothyroidism may affect fetal growth and neonatal thyroid function. Obstet Gynecol 2003; 102:232-241. This paper reminds readers of the effects of hypothyroidism on the fetus, maternal treatment notwithstanding, and implies the need for long-term follow-up studies on the neuro-psychointellectual development of the offspring of these pregnancies.
32. Vulsma T, Gons MH, de Vijlder JJM. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect in thyroid agenesis. N Engl J Med 1989; 321:13-16.
33. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291:228-238. A detailed and balanced coverage of the background and management of subclinical thyroid disease, with an emphasis on the specific situation in pregnancy, is given in this paper.
34. Chopra IJ, Baber K. Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy? Metab Clin Exp 2003; 52:122-128. This paper explores the different needs for thyroxine replacement for hypothyroidism due to different causes in pregnant women.